Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback